<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Bone and soft tissue sarcomas, tumors of the skin</journal-id><journal-title-group><journal-title xml:lang="en">Bone and soft tissue sarcomas, tumors of the skin</journal-title><trans-title-group xml:lang="ru"><trans-title>Саркомы костей, мягких тканей и опухоли кожи</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2219-4614</issn><issn publication-format="electronic">2782-3687</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">317</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>BONE SARCOMAS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>САРКОМЫ КОСТЕЙ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Experience of bone tumors treatment in the Kyrgyz National Center of Oncology and Hematology</article-title><trans-title-group xml:lang="ru"><trans-title>Опыт лечения опухолей костей в Национальном Центре Онкологии и Гематологии (г. Бишкек, Киргизская Республика)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Alymkulov</surname><given-names>A. T.</given-names></name><name xml:lang="ru"><surname>Алымкулов</surname><given-names>А. Т.</given-names></name></name-alternatives><address><country country="KG">Kyrgyzstan</country></address><bio xml:lang="ru"><p>г. Бишкек</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Babalaev</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Бабалаев</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="KG">Kyrgyzstan</country></address><bio xml:lang="ru"><p>г. Бишкек</p></bio><email>Babalaev@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Djunushaliev</surname><given-names>K. K.</given-names></name><name xml:lang="ru"><surname>Джунушалиев</surname><given-names>К. К.</given-names></name></name-alternatives><address><country country="KG">Kyrgyzstan</country></address><bio xml:lang="ru"><p>г. Бишкек</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Abdyldaev</surname><given-names>T. A.</given-names></name><name xml:lang="ru"><surname>Абдылдаев</surname><given-names>Т. А.</given-names></name></name-alternatives><address><country country="KG">Kyrgyzstan</country></address><bio xml:lang="ru"><p>г. Бишкек</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Beyshembaev</surname><given-names>A. M.</given-names></name><name xml:lang="ru"><surname>Бейшембаев</surname><given-names>А. М.</given-names></name></name-alternatives><address><country country="KG">Kyrgyzstan</country></address><bio xml:lang="ru"><p>г. Бишкек</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">National Center of Oncology and Hematology of the Ministry of Health of the Kyrgyz Republic</institution></aff><aff><institution xml:lang="ru">Национальный Центр Онкологии и Гематологии Минздрава Киргизской Республики</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2017</year></pub-date><volume>9</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>21</fpage><lpage>27</lpage><history><date date-type="received" iso-8601-date="2022-01-15"><day>15</day><month>01</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-01-15"><day>15</day><month>01</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Alymkulov A.T., Babalaev A.A., Djunushaliev K.K., Abdyldaev T.A., Beyshembaev A.M.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, Алымкулов А.Т., Бабалаев А.А., Джунушалиев К.К., Абдылдаев Т.А., Бейшембаев А.М.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Alymkulov A.T., Babalaev A.A., Djunushaliev K.K., Abdyldaev T.A., Beyshembaev A.M.</copyright-holder><copyright-holder xml:lang="ru">Алымкулов А.Т., Бабалаев А.А., Джунушалиев К.К., Абдылдаев Т.А., Бейшембаев А.М.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://sarbon.abvpress.ru/jour/article/view/317">https://sarbon.abvpress.ru/jour/article/view/317</self-uri><abstract xml:lang="en"><p>Among malignant tumors, tumor lesions of the skeleton are relatively rare. However, most often disease affects young people of active age. Skeletal tumors often lead to disability of the patient. Thus, bone tumors are not just purely medical problem, but also a social one. Research of effective treatment for this group of patients remains an urgent task among orthopedic oncology.</p></abstract><trans-abstract xml:lang="ru"><p>Опухолевое поражение скелета относительно редкий вид патологии в структуре злокачественных опухолей. Однако, поражая чаще всего лиц молодого, трудоспособного населения, опухоли скелета нередко приводят к инвалидизации больного. Таким образом, опухоли костей из плоскости чисто медицинской переходят в плоскость социальной проблемы. Поиск эффективного лечения данной категории больных остается актуальной задачей в практике онкологической ортопедии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>bone sarcomas</kwd><kwd>benign bone tumors</kwd><kwd>metastatic skeletal disease</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>саркомы костей</kwd><kwd>доброкачественные опухоли костей</kwd><kwd>метастатическое поражение скелета</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Заридзе Д.Г. Архив патологии. 2003, № 2, с. 53-61.</mixed-citation><mixed-citation xml:lang="ru">Заридзе Д.Г. Архив патологии. 2003, № 2, с. 53-61.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Ганцев Ш.Х. Онкология. М., 2004, с. 433-464.</mixed-citation><mixed-citation xml:lang="ru">Ганцев Ш.Х. Онкология. М., 2004, с. 433-464.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Давыдов М.И. Энциклопедия клинической онкологии. М., 2004, с. 60-89.</mixed-citation><mixed-citation xml:lang="ru">Давыдов М.И. Энциклопедия клинической онкологии. М., 2004, с. 60-89.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Liu F., Zhang Q., Zhu D. et al. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcomas. Medicine (Baltimore). 2015, v. 94 (36), e1462.</mixed-citation><mixed-citation xml:lang="ru">Liu F., Zhang Q., Zhu D. et al. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcomas. Medicine (Baltimore). 2015, v. 94 (36), e1462.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. NCI. SEER Cancer Statistics Review, 1975–2008. National Cancer Institute. 2011. http://ser.cancer.gov/csr/1975_2008/.</mixed-citation><mixed-citation xml:lang="ru">NCI. SEER Cancer Statistics Review, 1975–2008. National Cancer Institute. 2011. http://ser.cancer.gov/csr/1975_2008/.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Fletcher C.D.M., Bridge J.A., Hogendoorn P.C.W. et al. Pathology and Genetics of Tumours of Soft Tissue and Bone. 4th ed. Lyon: IARC Press. 2013.</mixed-citation><mixed-citation xml:lang="ru">Fletcher C.D.M., Bridge J.A., Hogendoorn P.C.W. et al. Pathology and Genetics of Tumours of Soft Tissue and Bone. 4th ed. Lyon: IARC Press. 2013.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Rehan N., Bieling P., Winkler P. et al. The prognostic significance of tumor volume in osteosarcoma with neoadjuvant chemotherapy. Klin. Padiatr. 1993, v. 205, p. 200-209. (In German).</mixed-citation><mixed-citation xml:lang="ru">Rehan N., Bieling P., Winkler P. et al. The prognostic significance of tumor volume in osteosarcoma with neoadjuvant chemotherapy. Klin. Padiatr. 1993, v. 205, p. 200-209. (In German).</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Bielack S.S., Kempf-Bielack B., Delling G. et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J. Clin. Oncol. 2002, v. 20, p. 776-790.</mixed-citation><mixed-citation xml:lang="ru">Bielack S.S., Kempf-Bielack B., Delling G. et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J. Clin. Oncol. 2002, v. 20, p. 776-790.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Ferrari S., Bertoni F., Mercuri M., Picci P., Giacomini S., Longhi A., Bacci G. Predictive factors of disease-free survival for nonmetastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann. Oncol. 2001, v. 12, p. 1145-1150.</mixed-citation><mixed-citation xml:lang="ru">Ferrari S., Bertoni F., Mercuri M., Picci P., Giacomini S., Longhi A., Bacci G. Predictive factors of disease-free survival for nonmetastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann. Oncol. 2001, v. 12, p. 1145-1150.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Pochanugool L., Subhadharaphandou T., Dhanachai M., HathiratP., Sangthawan D., Pirabul R., Onsanit S., Pornpipatpong N. Prognostic factors among 130 patients with osteosarcoma. Clin. Orthop. Relat. Res. 1997, v. 345, p. 206-214.</mixed-citation><mixed-citation xml:lang="ru">Pochanugool L., Subhadharaphandou T., Dhanachai M., HathiratP., Sangthawan D., Pirabul R., Onsanit S., Pornpipatpong N. Prognostic factors among 130 patients with osteosarcoma. Clin. Orthop. Relat. Res. 1997, v. 345, p. 206-214.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Bacci G., LonghiA., BertoniF., BacchiniP., RuggeriP., Versari M., Picci P. Primary high-grade osteosarcoma: comparison between preadolescent and older patients. J. Pediatr. Hematol. Oncol. 2005, v. 27, p. 129-134.</mixed-citation><mixed-citation xml:lang="ru">Bacci G., LonghiA., BertoniF., BacchiniP., RuggeriP., Versari M., Picci P. Primary high-grade osteosarcoma: comparison between preadolescent and older patients. J. Pediatr. Hematol. Oncol. 2005, v. 27, p. 129-134.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Алиев М.Д., Сушенцов Е.А. Современная онкоортопедия. Саркомы костей, мягких тканей и опухоли кожи. 2012, № 4, с. 3-10.</mixed-citation><mixed-citation xml:lang="ru">Алиев М.Д., Сушенцов Е.А. Современная онкоортопедия. Саркомы костей, мягких тканей и опухоли кожи. 2012, № 4, с. 3-10.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
